CRISIL Limited (BOM: 500092)
India
· Delayed Price · Currency is INR | Market Cap | 401.57B |
| Revenue (ttm) | 32.65B |
| Net Income (ttm) | 6.70B |
| Shares Out | n/a |
| EPS (ttm) | 91.56 |
| PE Ratio | 59.98 |
| Forward PE | n/a |
| Dividend | 58.00 (1.04%) |
| Ex-Dividend Date | Oct 30, 2024 |
| Volume | 2,870 |
| Average Volume | 3,538 |
| Open | 5,590.40 |
| Previous Close | 5,585.65 |
| Day's Range | 5,478.50 - 5,682.20 |
| 52-Week Range | 3,665.10 - 6,955.40 |
| Beta | n/a |
| RSI | 41.97 |
| Earnings Date | Feb 10, 2025 |
About CRISIL
CRISIL Limited, an analytical company, together with its subsidiaries, provides ratings, data, research, and analytics and solutions worldwide. It operates through two segment, Rating Services; and Research, Analytics, and Solutions. The Ratings Services segment offers credit ratings for corporates, banks, and bank loans; credit analysis services; grading services; and analytical services. The Research, Analytics, and Solutions segment provides research and risk solutions, industry reports, customized research assignments, subscription to data ... [Read more]
Financial Performance
In 2023, CRISIL's revenue was 31.40 billion, an increase of 13.39% compared to the previous year's 27.69 billion. Earnings were 6.58 billion, an increase of 16.66%.
Financial StatementsNews
Top gainers today: Piramal Pharma surges 5.85%, CRISIL rises 3.63%, Aditya Birla Capital gains 2.76%, AstraZeneca Pharma up 2.57%
At 12:53 PM, the stock market witnessed notable gains across several stocks. Here’s a look at the top performers: Piramal Pharma Limited (PPL Pharma): The stock climbed 5.85%, trading at ₹234.20. CRIS...
CRISIL invests Rs 33.25 Crore in online PSB Loans
CRISIL Limited has announced an investment of ₹33.25 crore to acquire a 4.08% post-money, fully diluted stake in Online PSB Loans Limited (OPL). This strategic move was approved during a board meeting...